{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T04:46:56Z","timestamp":1769748416498,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"vor","delay-in-days":191,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2020]]},"DOI":"10.6061\/clinics\/2020\/e1610","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T16:03:44Z","timestamp":1594742624000},"page":"e1610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Benzodiazepine use in Sao Paulo, Brazil"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1845-8311","authenticated-orcid":false,"given":"Angela Maria","family":"Campanha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6077-9461","authenticated-orcid":false,"given":"Beatriz","family":"Ravagnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3649-0358","authenticated-orcid":false,"given":"Igor Andr\u00e9","family":"Milhoran\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7922-6747","authenticated-orcid":false,"given":"M\u00e1rcio Antonini","family":"Bernik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0464-4845","authenticated-orcid":false,"given":"Maria Carmen","family":"Viana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7076-8312","authenticated-orcid":false,"given":"Yuan-Pang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2362-3521","authenticated-orcid":false,"given":"Laura Helena","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1-2","key":"10.6061\/clinics\/2020\/e1610_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/0740-5472(91)90027-8","article-title":"History of benzodiazepine dependence","volume":"8","author":"Lader","year":"1991","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"10.6061\/clinics\/2020\/e1610_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-2007-979558","article-title":"Long-term use of benzodiazepines: tolerance, dependence and clinical problems in anxiety and mood disorders","volume":"29","author":"Michelini","year":"1996","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"10.6061\/clinics\/2020\/e1610_bib3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/026988119500900404","article-title":"Impairment of performance associated with long-term use of benzodiazepines","volume":"9","author":"Gorenstein","year":"1995","journal-title":"J Psychopharmacol"},{"issue":"5","key":"10.6061\/clinics\/2020\/e1610_bib4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1755-5949.2010.00167.x","article-title":"Acute drug administration in epilepsy: a review","volume":"17","author":"Wolf","year":"2011","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"10.6061\/clinics\/2020\/e1610_bib5","article-title":"Benzodiazepines for alcohol withdrawal","author":"Amato","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.6061\/clinics\/2020\/e1610_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5811\/westjem.2011.9.6866","article-title":"The psychopharmacology of agitation: consensus statement of the American association for emergency psychiatry project Beta psychopharmacology workgroup","volume":"13","author":"Wilson","year":"2012","journal-title":"West J Emerg Med"},{"issue":"5","key":"10.6061\/clinics\/2020\/e1610_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5664\/jcsm.27286","article-title":"Clinical guideline for the evaluation and management of chronic insomnia in adults","volume":"4","author":"Schutte-Rodin","year":"2008","journal-title":"J Clin Sleep Med"},{"key":"10.6061\/clinics\/2020\/e1610_bib8","series-title":"Practice guidelines for the treatment of patients with panic disorder. 2nd ed","author":"Stein","year":"2009"},{"issue":"Suppl 1","key":"10.6061\/clinics\/2020\/e1610_bib9","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-244X-14-S1-S1","article-title":"Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress, and obsessive-compulsive disorders","volume":"14","author":"Katzman","year":"2014","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.6061\/clinics\/2020\/e1610_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord"},{"key":"10.6061\/clinics\/2020\/e1610_bib11","series-title":"Meyler's Side effects of drug: the international encyclopedia of adverse drug reactions and interactions. 15th ed","author":"Aronson","year":"2006"},{"issue":"2","key":"10.6061\/clinics\/2020\/e1610_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF02246094","article-title":"Encoding, remembering and awareness in lorazepam-induced amnesia","volume":"122","author":"Curran","year":"1995","journal-title":"Psychopharmacology"},{"issue":"11","key":"10.6061\/clinics\/2020\/e1610_bib13","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/j.1360-0443.1994.tb03743.x","article-title":"The benzodiazepine withdrawal syndrome","volume":"89","author":"P\u00e9tursson","year":"1994","journal-title":"Addiction"},{"key":"10.6061\/clinics\/2020\/e1610_bib14","series-title":"Generalised anxiety disorder and panic disorder in adults: management","author":"National Institute for Health and Care Excellence","year":"2011"},{"issue":"2","key":"10.6061\/clinics\/2020\/e1610_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/acps.12909","article-title":"The risk of Alzheimer\u2019s disease associated with benzodiazepines and related drugs: a nested case-control study","volume":"138","author":"Tapiainen","year":"2018","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"10.6061\/clinics\/2020\/e1610_bib16","first-page":"181","article-title":"Consommation de m\u00e9dicaments psychotropes dans la population belge: R\u00e9sultats de l'European Study of the Epidemiology of Mental Disorders (ESEMeD) [Psychotropic drug use in the Belgian non-institutionalized population]","volume":"60","author":"Bruffaerts","year":"2005","journal-title":"Rev Med Liege"},{"issue":"2","key":"10.6061\/clinics\/2020\/e1610_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0013-7006(05)82386-3","volume":"31","author":"Gasquet","year":"2005","journal-title":"Encephale"},{"issue":"Suppl 2","key":"10.6061\/clinics\/2020\/e1610_bib18","first-page":"29","article-title":"Uso de f\u00e1rmacos psicotr\u00f3picos en Espa\u00e3a. Resultados del estudio ESEMeD-Espa\u00e3a [Psychotropic medications use in Spain. Results of the ESEMeD-Spain study]","volume":"35","author":"Codony","year":"2007","journal-title":"Actas Esp Psiquiatr"},{"issue":"5","key":"10.6061\/clinics\/2020\/e1610_bib19","first-page":"356","article-title":"Psychotropic drug use in Israel: results from the national health survey","volume":"9","author":"Grinshpoon","year":"2007","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"11","key":"10.6061\/clinics\/2020\/e1610_bib20","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/pds.3826","article-title":"Use of psychotropic medications in S\u00e3o Paulo Metropolitan Area, Brazil: pattern of healthcare provision to general population","volume":"24","author":"Campanha","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.6061\/clinics\/2020\/e1610_bib21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/09638230500195221","article-title":"Use of psychotropic medication in Santiago, Chile","volume":"14","author":"Rojas","year":"2005","journal-title":"J Mental Health"},{"issue":"5","key":"10.6061\/clinics\/2020\/e1610_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062270","article-title":"Epidemiology of psychotropic drug use in Rio de Janeiro, Brazil: gaps in mental illness treatments","volume":"8","author":"Quintana","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.6061\/clinics\/2020\/e1610_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135059","article-title":"Psychotropic Drug Use in S\u00e3o Paulo, Brazil-An Epidemiological Survey","volume":"10","author":"Quintana","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.6061\/clinics\/2020\/e1610_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031879","article-title":"Mental disorders in megacities: findings from the S\u00e3o Paulo megacity mental health survey, brazil","volume":"7","author":"Andrade","year":"2012","journal-title":"PLoS One"},{"issue":"420","key":"10.6061\/clinics\/2020\/e1610_bib25","first-page":"55","article-title":"Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project","author":"Alonso","year":"2004","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"2","key":"10.6061\/clinics\/2020\/e1610_bib26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.6061\/clinics\/2020\/e1610_bib27","series-title":"Aspectos Epidemiol\u00f3gicos do Consumo de Medicamentos Psicotr\u00f3picos pela Popula\u00e7\u00e3o de Adultos do Distrito de S\u00e3o Paulo [dissertation]","author":"Tancredi","year":"1979"},{"issue":"2","key":"10.6061\/clinics\/2020\/e1610_bib28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1017\/S0033291700028555","article-title":"The epidemiology of psychotropic use in the city of S\u00e3o Paulo","volume":"23","author":"Mari","year":"1993","journal-title":"Psychol Med"},{"issue":"1-2","key":"10.6061\/clinics\/2020\/e1610_bib29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jad.2008.01.011","article-title":"Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD)","volume":"110","author":"Demyttenaere","year":"2008","journal-title":"J Affect Disord"},{"issue":"2-3","key":"10.6061\/clinics\/2020\/e1610_bib30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.healthpol.2010.03.008","article-title":"Patterns in the use of benzodiazepines in British Columbia: examining the impact of increasing research and guideline cautions against long-term use","volume":"97","author":"Cunningham","year":"2010","journal-title":"Health Policy"},{"issue":"1","key":"10.6061\/clinics\/2020\/e1610_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40271-016-0182-z","article-title":"A Systematic Review and Meta-Synthesis of Patients\u2019 Experiences and Perceptions of Seeking and Using Benzodiazepines and Z-Drugs: Towards Safer Prescribing","volume":"10","author":"Sirdifield","year":"2017","journal-title":"Patient"},{"issue":"3","key":"10.6061\/clinics\/2020\/e1610_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/09540260500071863","article-title":"The epidemiology of long-term benzodiazepine use","volume":"17","author":"Neutel","year":"2005","journal-title":"Int Rev Psychiatry"},{"issue":"11","key":"10.6061\/clinics\/2020\/e1610_bib33","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults","volume":"63","author":"By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"10.6061\/clinics\/2020\/e1610_bib34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/2042098613486829","article-title":"Drug-related falls in older patients: implicated drugs, consequences, and possible prevention strategies","volume":"4","author":"de Jong","year":"2013","journal-title":"Ther Adv Drug Saf"},{"issue":"2","key":"10.6061\/clinics\/2020\/e1610_bib35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/pds.686","article-title":"Medication use and risk of falls","volume":"11","author":"Neutel","year":"2002","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.6061\/clinics\/2020\/e1610_bib36","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2125.2007.03060.x","article-title":"Determinants of chronic benzodiazepine use in the elderly: a longitudinal study","volume":"65","author":"Luijendijk","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.6061\/clinics\/2020\/e1610_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e6231","article-title":"Benzodiazepine use and risk of dementia: prospective population based study. Version 2","volume":"345","author":"Billioti de Gage","year":"2012","journal-title":"BMJ"},{"key":"10.6061\/clinics\/2020\/e1610_bib38","doi-asserted-by":"crossref","first-page":"g5205","DOI":"10.1136\/bmj.g5205","article-title":"Benzodiazepine use and risk of Alzheimer\u2019s disease: case-control study. Version 2","volume":"349","author":"Billioti de Gage","year":"2014","journal-title":"BMJ"},{"key":"10.6061\/clinics\/2020\/e1610_bib39","doi-asserted-by":"crossref","first-page":"i90","DOI":"10.1136\/bmj.i90","article-title":"Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study. Version 2","volume":"352","author":"Gray","year":"2016","journal-title":"BMJ"},{"key":"10.6061\/clinics\/2020\/e1610_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40360-015-0019-8","article-title":"Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review","volume":"16","author":"Pollmann","year":"2015","journal-title":"BMC Pharmacol Toxicol"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222003192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222003192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:55:32Z","timestamp":1761720932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222003192"},"secondary":[{"URL":"https:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1807-59322020000100247&lng=en&nrm=iso","label":"SCIELO"},{"URL":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7337218\/","label":"PMC"},{"URL":"https:\/\/www.clinicsjournal.com\/article\/benzodiazepine-use-in-sao-paulo-brazil\/","label":"CLINICS"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":40,"alternative-id":["S1807593222003192"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2020\/e1610","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benzodiazepine use in Sao Paulo, Brazil","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2020\/e1610","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}],"article-number":"e1610"}}